Bharat Parenterals Limited BPLPHARMA.BO BSE · Healthcare · India
₹2,408.00 +9.16% +₹202.05
Summary
35 / 100 · Bulios Score
What speaks for it
- Revenue grew by 17% a year over the last 3 years.
What to watch
- Operating profit does not even cover the interest on its debt.
- Out of every 100 INR of revenue, only 0.3 INR is left as net profit.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveToday you pay 1,227.6 INR for 1 INR of yearly profit. Over the last five years it was 22.0 INR on average.
Valuation in detailIs it growing?
Yes, fastRevenue (INR)
Diluted EPS (INR)
Revenue grew by 11% a year over 5 years. Over the last 3 years it grew by 17% a year.
Growth in detailDoes it make money?
PoorlyWhere 100 INR of revenue goes
- Cost of sales 80 INR
- Sales and administration 20 INR
- Taxes and other -0.7 INR
- Net profit 0.3 INR
Net profit, industry median (Medical - Pharmaceuticals) 6.1 INR
Out of every 100 INR of revenue, 0.3 INR is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenIts debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 0.05%
- Paid out of profit
- 55%
You receive ₹1.00 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail